Longitudinal preclinical magnetic resonance imaging of diffuse tumor burden in intramedullary myeloma following bortezomib therapy.
NMR Biomed
; 32(9): e4122, 2019 09.
Article
in En
| MEDLINE
| ID: mdl-31206946
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Magnetic Resonance Imaging
/
Tumor Burden
/
Bortezomib
/
Multiple Myeloma
Type of study:
Guideline
/
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
NMR Biomed
Journal subject:
DIAGNOSTICO POR IMAGEM
/
MEDICINA NUCLEAR
Year:
2019
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom